Liquid chromatography-quadrupole time of flight-mass spectrometry was used to evaluate the different lipid metabolites in serum samples obtained from the participants ( 21 patients in glipizide group and 23 patients in metformin group ) before and after each year of treatment ( at 0 [ baseline ] , 1 , 2 , and 3 years of study drug administration ) .